Dr. Landovitz is Professor of Medicine in the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA and is the Co-director of the UCLA Center for Clinical AIDS Research & Education (CARE) and of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS).
He serves on the Executive Committee of the HIV Prevention Trials Network and was awarded the HIVMA HIV Research Award in 2017.
Dr. Landovitz's research agenda focuses on the optimization of the use of antiretroviral medications for both HIV treatment and HIV prevention. He has led numerous clinical trials, and currently leads
the NIH trials developing long-acting injectable cabotegravir for HIV prevention.
Tonya [dot] Reid [at] nyspi [dot] columbia [dot] edu